Abstract Purpose of Review Chemotherapy-induced peripheral neuropathy (CIPN) is a
debilitating and often painful condition that occurs after administration of chemotherapeutic …

Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a painful condition,
experienced by patients undergoing chemotherapy with some specific drugs, such as …

Satellite glial cells (SGCs) are among the most abundant non-neuronal cells in dorsal root
ganglia (DRGs) and closely envelop sensory neurons that detect painful stimuli. However …

Abstract Background and Aims The expanding use of chemotherapy in curative cancer
treatment has simultaneously resulted in a substantial and growing cohort of cancer …

Abstract Alterations in calcium (Ca 2+) signaling is a major mechanism in the development
of chemotherapy-induced peripheral neuropathy (CIPN), a side effect caused by multiple …

Introduction Chemotherapy-induced peripheral neuropathy (CIPN) is a common
consequence of cancer treatment and pain is a frequent complaint of the patients. Paclitaxel …

Chemotherapy-induced peripheral neuropathy is one of the most frequent dose-limiting side
effects, observed in patients receiving antineoplastic agents, persisting for up to two years …

Chemotherapy-induced peripheral neuropathy (CIPN)-mediated paresthesias are a
common complication in cancer patients undergoing chemotherapy. There are currently no …

Chemotherapy-induced peripheral neuropathy is a common adverse effect associated with
a number of chemotherapeutic agents including paclitaxel (PTX) which is used in a wide …

Although sympathetic blockade is clinically used to treat pain, the underlying mechanisms
remain unclear. We developed a localized microsympathectomy (mSYMPX), by cutting the …